Arthritis drugs raise cancer risk in kids: FDA
Blockbuster prescription drugs used to treat rheumatoid arthritis and other conditions can increase the risk of potentially deadly cancer in children and teenagers, U.S. health regulators said on Tuesday in ordering stronger warnings on such medications.
Vitamin D may help prevent knee osteoarthritis
Low levels of vitamin D are associated with the loss of cartilage in the knee joint of older individuals, researchers in Australia report.
Guidance for Assessing Arthritis Pain Medications Usage
Treatment guidelines exist to help physicians choose the best treatment options for their patients based on current scientific studies.
Roche says data show Actemra effectiveness
Swiss drugmaker Roche Holding AG said on Monday new two-year data showed the effectiveness of its Actemra drug in inhibiting structural damage to the joints of patient with rheumatoid arthritis.
Bristol-Myers and Repligen Corp. Settle Lawsuit with $5 Million
Bristol-Myers Squibb Co. agreed today to pay $5 million plus royalties to Repligen Corp. to settle a patent infringement lawsuit for a rheumatoid arthritis treatment.
Schering-Plough profit eclipses expectations
Schering-Plough Corp. on Monday reported quarterly earnings far higher than Wall Street expected, fueled by growing demand for its drugs against cholesterol, arthritis, allergies and hepatitis C.